Trevena
TRVN
#10609
Rank
NZ$0.01 M
Marketcap
NZ$0.02077
Share price
0.00%
Change (1 day)
-99.27%
Change (1 year)

P/E ratio for Trevena (TRVN)

P/E ratio as of December 2025 (TTM): -0.0003

According to Trevena's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.000345423. At the end of 2022 the company had a P/E ratio of -0.1855.

P/E ratio history for Trevena from 2014 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2022-0.1855-90.14%
2021-1.88-78.91%
2020-8.92
2018-1.00
2016-3.00-67.14%
2015-9.13

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Amgen
AMGN
25.5-7,384,900.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-10.5 3,050,478.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-0.2533 73,239.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
13.2-3,809,371.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-0.2783 80,472.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.